Syncom Formulations (India) Ltd: A Rising Star in the Pharmaceutical Industry
Syncom Formulations (India) Ltd, a smallcap pharmaceutical company, has gained attention in the stock market with its recent performance. On September 12, 2024, the stock rose by 7.23%, outperforming the sector by 3.92%. This is due to the company's strong financials and potential for growth, as indicated by a 'Buy' call from leading stock analysis platform MarketsMojo. The stock has also shown a trend reversal and is trading higher than its moving averages, outperforming the Sensex with a 1-day performance of 6.22% and a 1-month performance of 64.58%. With its impressive performance and positive outlook, Syncom Formulations (India) Ltd is a stock to keep an eye on.
Syncom Formulations (India) Ltd, a smallcap pharmaceutical company, has been making waves in the stock market with its recent performance. On September 12, 2024, the company's stock gained an impressive 7.23%, outperforming the sector by 3.92%. This positive trend is a result of the company's strong financials and promising growth prospects.
MarketsMOJO, a leading stock analysis platform, has given a 'Buy' call for Syncom Formulations (India) Ltd. This is a testament to the company's potential and the confidence of experts in its future performance.
The stock has also shown a trend reversal, gaining after two consecutive days of fall. This indicates a strong buying sentiment among investors and a positive outlook for the company.
Syncom Formulations (India) Ltd has also been trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, further solidifying its position in the market.
In comparison to the Sensex, the company's stock has outperformed with a 1-day performance of 6.22% and a 1-month performance of 64.58%. This is a significant achievement for a smallcap company in the pharmaceutical industry.
With its strong performance and promising future, Syncom Formulations (India) Ltd is definitely a stock to watch out for. Investors can expect continued growth and success from this company in the coming days.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
